ENTITY
Grifols SA

Grifols SA (GRF SM)

67
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
11 Oct 2019 18:09

Grifols' (GRF) Bleeding Prefs

Grifols Class B shares listed on Nasdaq (GFRS US) are trading at a 33.4% discount to Grifols class A shares (GFR SM), listed in Spain. I regard...

Share
20 Sep 2019 03:06

China Biologic's Privatisation Redux

On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...

Logo
509 Views
Share
12 Aug 2019 09:31

Global Equity Strategy: Another Test of Support

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...

Logo
400 Views
Share
x